AJANTA PHARMA (AJANTPHARM.NS) Financials
AJANTPHARM.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 46.4 billion | 10.7 billion |
| 2023-12-31 | ? | ? |
| 2023-09-30 | 44.3 billion | 9.5 billion |
| 2023-06-30 | ? | ? |
AJANTPHARM.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | 685.2 million | ? |
| 2023-09-30 | 674.2 million | ? |
| 2023-06-30 | 663.6 million | ? |
AJANTPHARM.NS Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 2.0 billion |
| 2023-12-31 | 2.1 billion |
| 2023-09-30 | 2.0 billion |
| 2023-06-30 | 2.1 billion |
AJANTPHARM.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 4.6 billion | - | 337.9 million |
| 2023-12-31 | 4.8 billion | - | - |
| 2023-09-30 | 4.8 billion | 224.7 million | 321.1 million |
| 2023-06-30 | 8.4 billion | - | - |
AJANTPHARM.NS Shares Outstanding
AJANTPHARM.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 500.0 million | - | - |
| 2023-12-31 | - | 520.0 million | - | - |
| 2023-09-30 | 611.5 million | 500.0 million | 2.2 billion | - |
| 2023-06-30 | - | 550.0 million | 2.1 billion | - |
AJANTPHARM.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 10.5 billion | 5.3 billion |
| 2023-12-31 | 11.1 billion | 2.9 billion |
| 2023-09-30 | 10.3 billion | 2.6 billion |
| 2023-06-30 | 10.2 billion | 2.5 billion |
AJANTPHARM.NS
Price: ₹2,381.05
Dividend Yield: 0.02%
Forward Dividend Yield: 2.18%
Payout Ratio: 89.39%
Dividend Per Share: 52.00 INR
Earnings Per Share: 64.67 INR
P/E Ratio: 37.26
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 299.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19
DGR3: -5.47%
DGR5: 11.32%
DGR10: 30.00%